1 |
34082607 |
10.1177/11206721211023309 |
2022 |
Follicular lymphoma of the ocular adnexa: Clinicopathological findings with flow cytometry analysis of eight cases. |
BCL2 |
2 |
34180720 |
10.1177/10668969211027409 |
2022 |
Aggressive Cyclin D1 Negative Blastoid Variant Mantle Cell Lymphoma-A Case Report. |
BCL2 |
3 |
34184213 |
10.1007/s12011-021-02802-2 |
2022 |
Borax Pentahydrate and Disodium Pentaborate Decahydrate Are Candidates as Anti-leukemic Drug Components by Inducing Apoptosis and Changing Bax/Bcl-2 Ratio in HL-60 Cell Line. |
BCL2 |
4 |
34236820 |
10.21470/1678-9741-2020-0549 |
2022 |
The Protective Effect of Kaempferol Against Ischemia/Reperfusion Injury Through Activating SIRT3 to Inhibit Oxidative Stress. |
BCL2 |
5 |
34265801 |
10.1097/PAS.0000000000001780 |
2022 |
Plasticity of Mature B Cells Between Follicular and Classic Hodgkin Lymphomas: A Series of 22 Cases Expanding the Spectrum of Transdifferentiation. |
BCL2 |
6 |
34289655 |
10.3324/haematol.2021.278638 |
2022 |
Dose-adjusted EPOCH and rituximab for the treatment of double expressor and double-hit diffuse large B-cell lymphoma: impact of TP53 mutations on clinical outcome. |
BCL2 |
7 |
34304248 |
10.1038/s41375-021-01347-6 |
2022 |
Dual targeting of the DNA damage response pathway and BCL-2 in diffuse large B-cell lymphoma. |
BCL2 |
8 |
34332791 |
10.1016/j.pathol.2021.04.008 |
2022 |
Morphologic and molecular analysis of Richter syndrome in chronic lymphocytic leukaemia patients treated with ibrutinib or venetoclax. |
BCL2 |
9 |
34353221 |
10.1080/15376516.2021.1965276 |
2022 |
Concerted hepatoprotective effect of bradykinin potentiating factor and low dose of γ- radiation on <i>Naja haje</i> envenomed rats <i>via</i> Bax/Bcl2 pathway. |
BCL2 |
10 |
34392269 |
10.1097/PAS.0000000000001750 |
2022 |
Mutational Landscape of TdT+ Large B-cell Lymphomas Supports Their Distinction From B-lymphoblastic Neoplasms: A Multiparameter Study of a Rare and Aggressive Entity. |
BCL2 |
11 |
34411492 |
10.1139/cjpp-2021-0007 |
2022 |
Colchicine attenuates renal ischemia-reperfusion-induced liver damage: implication of TLR4/NF-κB, TGF-β, and <i>BAX</i> and <i>Bcl-2</i> gene expression. |
BCL2 |
12 |
34417692 |
10.1007/s11356-021-15985-x |
2022 |
Landfill soil leachates from Nigeria and India induced DNA damage and alterations in genes associated with apoptosis in Jurkat cell. |
BCL2 |
13 |
34454850 |
10.1016/j.clml.2021.07.020 |
2022 |
Safety and Efficacy of a DNA Oligonucleotide Therapy in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma. |
BCL2 |
14 |
34456240 |
10.1097/PAI.0000000000000967 |
2022 |
Screening Strategy for Detecting Double-Hit Lymphoma in a Resource-Limited Setting. |
BCL2 |
15 |
34510996 |
10.1080/10428194.2021.1975189 |
2022 |
<i>BCL2</i> translocation in high grade B cell lymphoma (NOS, DH/TH) is associated with reduced progression free survival. |
BCL2 |
16 |
34515880 |
10.1007/s10238-021-00754-4 |
2022 |
Programmed cell death-ligand 1 (PD-L1)<sup>+</sup> tumour cells and low-reacting programmed cell death 1 (PD1)<sup>+</sup> tumour-infiltrating lymphocytes predict poor prognosis in Epstein-Barr virus<sup>+</sup> diffuse large B-cell lymphoma. |
BCL2 |
17 |
34519021 |
10.1111/bjh.17815 |
2022 |
Clinico-biological features and outcome of patients with splenic marginal zone lymphoma with histological transformation. |
BCL2 |
18 |
34528680 |
10.1093/ajcp/aqab128 |
2022 |
Recurrent Chromosomal Abnormalities in Tissues Involved by Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma. |
BCL2 |
19 |
34532813 |
10.1007/s11010-021-04257-4 |
2022 |
Tanshinone I restrains osteosarcoma progression by regulating circ_0000376/miR-432-5p/BCL2 axis. |
BCL2 |
20 |
34538551 |
10.1016/j.jfma.2021.08.015 |
2022 |
Mechanism of quercetin on the improvement of ovulation disorder and regulation of ovarian CNP/NPR2 in PCOS model rats. |
BCL2 |
21 |
34601504 |
10.1038/s41379-021-00938-z |
2022 |
Histopathologic, immunophenotypic, and mutational landscape of follicular lymphomas with plasmacytic differentiation. |
BCL2 |
22 |
34605949 |
10.1007/s00277-021-04671-0 |
2022 |
Characterization of molecular genetics and clinicopathology in thymic MALT lymphoma. |
BCL2 |
23 |
34608246 |
10.1038/s41379-021-00909-4 |
2022 |
Blastoid high-grade B-cell lymphoma initially presenting in bone marrow: a diagnostic challenge. |
BCL2 |
24 |
34615723 |
10.1158/1078-0432.CCR-21-2183 |
2022 |
Phase I/Ib Study of the Efficacy and Safety of Buparlisib and Ibrutinib Therapy in MCL, FL, and DLBCL with Serial Cell-Free DNA Monitoring. |
BCL2 |
25 |
34617271 |
10.1111/bjh.17874 |
2022 |
Epstein-Barr virus status of sporadic Burkitt lymphoma is associated with patient age and mutational features. |
BCL2 |
26 |
34624089 |
10.1182/blood.2021012327 |
2022 |
Oncogenic role of the SOX9-DHCR24-cholesterol biosynthesis axis in IGH-BCL2+ diffuse large B-cell lymphomas. |
BCL2 |
27 |
34632572 |
10.1111/bjh.17858 |
2022 |
Revised International Prognostic Index and genetic alterations are associated with early failure to R-CHOP in patients with diffuse large B-cell lymphoma. |
BCL2 |
28 |
34632715 |
10.1002/1878-0261.13115 |
2022 |
Targeting mitochondrial respiration and the BCL2 family in high-grade MYC-associated B-cell lymphoma. |
BCL2 |
29 |
34637146 |
10.1111/his.14585 |
2022 |
EBV<sup>+</sup> high-grade B cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements: a multi-institutional study. |
BCL2 |
30 |
34654055 |
10.1182/bloodadvances.2021006034 |
2022 |
Diffuse large B-cell lymphomas in adults with aberrant coexpression of CD10, BCL6, and MUM1 are enriched in IRF4 rearrangements. |
BCL2 |
31 |
34673010 |
10.1016/j.cbi.2021.109703 |
2022 |
The effects of agomelatine on endoplasmic reticulum stress related to mitochondrial dysfunction in hippocampus of aging rat model. |
BCL2 |
32 |
34710243 |
10.1002/ajh.26390 |
2022 |
Hairy cell leukemia 2022: Update on diagnosis, risk-stratification, and treatment. |
BCL2 |
33 |
34713475 |
10.1002/hon.2943 |
2022 |
Treatment strategies for a rapidly evolving landscape in chronic lymphocytic leukemia management. |
BCL2 |
34 |
34727403 |
10.1111/pin.13182 |
2022 |
AID is a poor prognostic marker of high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements. |
BCL2 |
35 |
34727633 |
10.5713/ab.21.0371 |
2022 |
Curcumin represses lipid accumulation through inhibiting ERK1/2-PPAR-γ signaling pathway and triggering apoptosis in porcine subcutaneous preadipocytes. |
BCL2 |
36 |
34727830 |
10.1080/10428194.2021.1998480 |
2022 |
Fish evaluation of additional cytogenetic aberrations and hyperdiploidy in childhood Burkitt lymphoma. |
BCL2 |
37 |
34728569 |
10.1158/1535-7163.MCT-21-0511 |
2022 |
Anti-apoptotic MCL1 Protein Represents Critical Survival Molecule for Most Burkitt Lymphomas and BCL2-negative Diffuse Large B-cell Lymphomas. |
BCL2 |
38 |
34730059 |
10.1080/08916934.2021.1995861 |
2022 |
Circ_0114427 promotes LPS-induced septic acute kidney injury by modulating miR-495-3p/TRAF6 through the NF-κB pathway. |
BCL2 |
39 |
34735897 |
10.1016/j.tranon.2021.101260 |
2022 |
A novel strategy for combination of clofarabine and pictilisib is synergistic in gastric cancer. |
BCL2 |
40 |
34739417 |
10.1097/PAS.0000000000001830 |
2022 |
Significance of Single-cell Level Dual Expression of BCL2 and MYC Determined With Multiplex Immunohistochemistry in Diffuse Large B-Cell Lymphoma. |
BCL2 |
41 |
34747234 |
10.1177/00031348211054526 |
2022 |
Primary Parotid Non-Hodgkin's B-Cell Lymphoma in an Elderly Woman on Pembrolizumab for Metastatic Invasive Papillary Urothelial Cell Carcinoma of the Bladder. |
BCL2 |
42 |
34752896 |
10.1016/j.cbpc.2021.109241 |
2022 |
Excessive manganese alters serum biochemical indices, induces histopathological alterations, and activates apoptosis in liver and cerebrum of Jianzhou Da'er goat (Capra hircus). |
BCL2 |
43 |
34756435 |
10.3168/jds.2021-20364 |
2022 |
Acute and chronic effects of cortisol on milk yield, the expression of key receptors, and apoptosis of mammary epithelial cells in Saanen goats. |
BCL2 |
44 |
34764434 |
10.1038/s41379-021-00962-z |
2022 |
BCL2 super-expressor diffuse large B-cell lymphoma: a distinct subgroup associated with poor prognosis. |
BCL2 |
45 |
34788985 |
10.3324/haematol.2021.279631 |
2022 |
Mutational landscape of high-grade B-cell lymphoma with <i>MYC-</i>, <i>BCL2</i> and/or <i>BCL6</i> rearrangements characterized by whole-exome sequencing. |
BCL2 |
46 |
34795418 |
10.1038/s41375-021-01470-4 |
2022 |
Inhibitors of Bcl-2 and Bruton's tyrosine kinase synergize to abrogate diffuse large B-cell lymphoma growth in vitro and in orthotopic xenotransplantation models. |
BCL2 |
47 |
34802044 |
10.1038/s41379-021-00954-z |
2022 |
A novel diagnostic approach for the classification of small B-cell lymphoid neoplasms based on the NanoString platform. |
BCL2 |
48 |
34821081 |
10.1002/cnr2.1590 |
2022 |
Mantle cell lymphoma: A clinical review of the changing treatment paradigms with the advent of novel therapies, and an insight into Indian data. |
BCL2 |
49 |
34837284 |
10.1111/cas.15224 |
2022 |
Decreased expression of T-cell-associated immune markers predicts poor prognosis in patients with follicular lymphoma. |
BCL2 |
50 |
34842019 |
10.1080/10428194.2021.2008383 |
2022 |
Fitting double-hit lymphoma into the aggressive lymphoma spectrum: a square peg in a round hole? |
BCL2 |
51 |
34848360 |
10.1016/j.jep.2021.114873 |
2022 |
Crocetin ameliorates non-alcoholic fatty liver disease by modulating mitochondrial dysfunction in L02 cells and zebrafish model. |
BCL2 |
52 |
34861556 |
10.1016/j.theriogenology.2021.11.017 |
2022 |
Expression of kisspeptin and its receptor in different functional classes of ovarian follicle in the buffalo (Bubalus bubalis). |
BCL2 |
53 |
34861696 |
10.1182/bloodadvances.2021006211 |
2022 |
Single-cell sequencing demonstrates complex resistance landscape in CLL and MCL treated with BTK and BCL2 inhibitors. |
BCL2 |
54 |
34864562 |
10.1016/j.theriogenology.2021.11.022 |
2022 |
Protegrin-1 inhibits porcine ovarian granulosa cell apoptosis from H<sub>2</sub>O<sub>2</sub>-induced oxidative stress via the PERK/eIF2α/CHOP signaling pathway in vitro. |
BCL2 |
55 |
34866456 |
10.1177/10668969211065110 |
2022 |
Endometrial Stromal Expression of ER, PR, and B-Catenin Toward Differentiating Hyperplasia Diagnoses. |
BCL2 |
56 |
34878357 |
10.1080/14737159.2022.2016394 |
2022 |
Association between serum concentrations of anti-apoptotic B-cell lymphoma-2 protein and traumatic brain injury mortality. |
BCL2 |
57 |
34896653 |
10.1016/j.jtct.2021.12.001 |
2022 |
Inhibition of IL-1 Receptor-Associated Kinase 1 Decreases Murine Acute Graft-versus-Host Disease While Preserving the Graft-versus-Lymphoma Effect. |
BCL2 |
58 |
34896889 |
10.1016/j.anndiagpath.2021.151868 |
2022 |
Merkel cell carcinoma in the setting of hematologic disease is associated with unique features and potential pitfalls. |
BCL2 |
59 |
34913064 |
10.3892/mmr.2021.12566 |
2022 |
Substance P prevents doxorubicin‑induced cardiomyocyte injury by regulating apoptosis and autophagy: <i>In vitro</i> and <i>in vivo</i> evidence. |
BCL2 |
60 |
34913076 |
10.3892/ijo.2021.5292 |
2022 |
Synergism of a novel MCL‑1 downregulator, acriflavine, with navitoclax (ABT‑263) in triple‑negative breast cancer, lung adenocarcinoma and glioblastoma multiforme. |
BCL2 |
61 |
34920187 |
10.1016/j.anireprosci.2021.106908 |
2022 |
Silver nanoparticles induce oxidative stress, apoptosis and impaired steroidogenesis in ovarian granulosa cells of cattle. |
BCL2 |
62 |
34922904 |
10.1016/j.cbi.2021.109779 |
2022 |
Diffuse large B-cell lymphoma-derived exosomes push macrophage polarization toward M2 phenotype via GP130/STAT3 signaling pathway. |
BCL2 |
63 |
34932207 |
10.1007/s40265-021-01657-0 |
2022 |
Current Treatment of Chronic Lymphocytic Leukemia: The Diminishing Role of Chemoimmunotherapy. |
BCL2 |
64 |
34932406 |
10.1139/cjpp-2021-0596 |
2022 |
Doxorubicin-induced apoptosis enhances monocyte infiltration and adverse cardiac remodeling in diabetic animals. |
BCL2 |
65 |
34932839 |
10.1111/and.14348 |
2022 |
Explore the effects of pulmonary fibrosis on sperm quality and the role of the PI3K/Akt pathway based on rat model. |
BCL2 |
66 |
34951009 |
10.1111/bjh.17971 |
2022 |
Prognostic impact of TP53 mutation in newly diagnosed diffuse large B-cell lymphoma patients treated in the FIL-DLCL04 trial. |
BCL2 |
67 |
34957565 |
10.1002/path.5861 |
2022 |
Widespread in situ follicular neoplasia in patients who subsequently developed follicular lymphoma. |
BCL2 |
68 |
34967008 |
10.1111/bjh.17990 |
2022 |
The molecular ontogeny of follicular lymphoma: gene mutations succeeding the BCL2 translocation define common precursor cells. |
BCL2 |
69 |
34980601 |
10.1158/1078-0432.CCR-21-2949 |
2022 |
Genetic Subtyping and Phenotypic Characterization of the Immune Microenvironment and MYC/BCL2 Double Expression Reveal Heterogeneity in Diffuse Large B-cell Lymphoma. |
BCL2 |
70 |
34984584 |
10.1007/s12035-021-02675-5 |
2022 |
Bax Contributes to Retinal Ganglion Cell Dendritic Degeneration During Glaucoma. |
BCL2 |
71 |
34990302 |
10.1080/21655979.2021.2017590 |
2022 |
Propofol induces the apoptosis of neural stem cells via microRNA-9-5p / chemokine CXC receptor 4 signaling pathway. |
BCL2 |
72 |
34994825 |
10.1007/s00210-021-02175-2 |
2022 |
Diacerein ameliorates induced polycystic ovary in female rats via modulation of inflammasome/caspase1/IL1β and Bax/Bcl2 pathways. |
BCL2 |
73 |
34994930 |
10.1007/s11356-021-18399-x |
2022 |
Histopathological, Immunohistochemical, And Molecular Alterations In Brain Tissue And Submandibular Salivary Gland Of Atrazine-Induced Toxicity In Male Rats. |
BCL2 |
74 |
34994989 |
10.1002/jcla.24227 |
2022 |
Association of B-cell lymphoma 2/microRNA-497 gene expression ratio score with metastasis in patients with colorectal cancer: A propensity-matched cohort analysis. |
BCL2 |
75 |
34999394 |
10.1016/j.intimp.2021.108497 |
2022 |
Venetoclax enhances NK cell killing sensitivity of AML cells through the NKG2D/NKG2DL activation pathway. |
BCL2 |
76 |
35007655 |
10.1016/j.dci.2022.104349 |
2022 |
SpBAG3 assisted WSSV infection in mud crab (Scylla paramamosain) by inhibiting apoptosis. |
BCL2 |
77 |
35013138 |
10.1038/s41420-021-00622-w |
2022 |
Knockdown of NRMT enhances sensitivity of retinoblastoma cells to cisplatin through upregulation of the CENPA/Myc/Bcl2 axis. |
BCL2 |
78 |
35028710 |
10.1007/s00428-021-03265-5 |
2022 |
Cell-of-origin classification using the Hans and Lymph2Cx algorithms in primary cutaneous large B-cell lymphomas. |
BCL2 |
79 |
35030632 |
10.1182/bloodadvances.2021006410 |
2022 |
Distinct clinical and genetic features of hepatitis B virus-associated follicular lymphoma in Chinese patients. |
BCL2 |
80 |
35036912 |
10.1177/2632010X211070774 |
2022 |
Rare but Potentially Fatal Presentations of Diffuse Large B-cell Lymphoma: Leukemic Phase or Hemophagocytic Syndrome in Bone Marrow. |
BCL2 |
81 |
35038193 |
10.1111/his.14617 |
2022 |
Incidence, clinicopathological features and genetics of in-situ follicular neoplasia: a comprehensive screening study in a Japanese cohort. |
BCL2 |
82 |
35044826 |
10.1126/sciadv.abl4644 |
2022 |
Preneoplastic somatic mutations including <i>MYD88</i><sup>L265P</sup> in lymphoplasmacytic lymphoma. |
BCL2 |
83 |
35045798 |
10.1080/10428194.2021.2024821 |
2022 |
High grade B-cell lymphoma with <i>MYC</i>, <i>BCL2</i> and/or <i>BCL6</i> rearrangements: unraveling the genetic landscape of a rare aggressive subtype of non-Hodgkin lymphoma. |
BCL2 |
84 |
35045920 |
10.1691/ph.2022.1670 |
2022 |
Anti-TIM1 suppresses airway inflammation and hyperresponsiveness via the STAT6 /STAT1 pathways in mice with allergic asthma. |
BCL2 |
85 |
35046056 |
10.1158/1078-0432.CCR-21-3617 |
2022 |
First-in-Human Dose-Escalation Study of Cyclin-Dependent Kinase 9 Inhibitor VIP152 in Patients with Advanced Malignancies Shows Early Signs of Clinical Efficacy. |
BCL2 |
86 |
35053500 |
10.3390/cancers14020338 |
2022 |
High ETV6 Levels Support Aggressive B Lymphoma Cell Survival and Predict Poor Outcome in Diffuse Large B-Cell Lymphoma Patients. |
BCL2 |
87 |
35058488 |
10.1038/s41598-022-04916-6 |
2022 |
Inhibition of MCL1 induces apoptosis in anaplastic large cell lymphoma and in primary effusion lymphoma. |
BCL2 |
88 |
35062067 |
10.1016/j.biopha.2021.112601 |
2022 |
Genistein alleviates renin-angiotensin system mediated vascular and kidney alterations in renovascular hypertensive rats. |
BCL2 |
89 |
35064305 |
10.1007/s00011-021-01535-1 |
2022 |
MiR-21 participates in LPS-induced myocardial injury by targeting Bcl-2 and CDK6. |
BCL2 |
90 |
35067515 |
10.1097/PAS.0000000000001828 |
2022 |
Composite Classic Hodgkin Lymphoma and Follicular Lymphoma: A Clinicopathologic Study of 22 Cases With Review of 27 Additional Cases in the Literature. |
BCL2 |
91 |
35068334 |
10.1080/21655979.2022.2026552 |
2022 |
Salvianolic acid B alleviates diabetic endothelial and mitochondrial dysfunction by down-regulating apoptosis and mitophagy of endothelial cells. |
BCL2 |
92 |
35074718 |
10.1016/j.theriogenology.2022.01.017 |
2022 |
The opposite effects of VGLL1 and VGLL4 genes on granulosa cell proliferation and apoptosis of hen ovarian prehierarchical follicles. |
BCL2 |
93 |
35089437 |
10.1007/s00018-022-04139-y |
2022 |
A20 undermines alternative NF-κB activity and expression of anti-apoptotic genes in Helicobacter pylori infection. |
BCL2 |
94 |
35132478 |
10.1007/s11064-022-03545-9 |
2022 |
Human Umbilical Cord Mesenchymal Stem Cells Derived Exosomes Promote Neurological Function Recovery in a Rat Spinal Cord Injury Model. |
BCL2 |
95 |
35141965 |
10.1111/ejn.15622 |
2022 |
Sevoflurane protects mice from cerebral ischaemic injury by regulating microRNA-203-3p/HDAC4/Bcl-2 axis. |
BCL2 |
96 |
35142981 |
10.1007/s11033-022-07203-9 |
2022 |
Apoptosis induction in human lung and colon cancer cells via impeding VEGF signaling pathways. |
BCL2 |
97 |
35151528 |
10.1016/j.blre.2022.100930 |
2022 |
CLL update 2022: A continuing evolution in care. |
BCL2 |
98 |
35152630 |
10.3760/cma.j.cn112151-20210826-00604 |
2022 |
[Clinicopathological features and prognosis of high-grade B-cell lymphoma with MYC and bcl-2 and/or bcl-6 rearrangements]. |
BCL2 |
99 |
35153031 |
10.1016/j.carbpol.2022.119097 |
2022 |
Co-delivery of doxorubicin and siRNA by all-trans retinoic acid conjugated chitosan-based nanocarriers for multiple synergistic antitumor efficacy. |
BCL2 |
100 |
35171311 |
10.1007/s00277-022-04785-z |
2022 |
CD37 expression in follicular lymphoma. |
BCL2 |